CALM IVF (Criando afiliações, aprendizado e atenção plena para pacientes de fertilização in vitro)
Criando afiliações, aprendizado e atenção plena para pacientes de fertilização in vitro
The investigators have designed a psychoeducational group curriculum specifically for new in vitro fertilization (IVF) patients (both male and female) to improve their treatment knowledge, to allow them to engage more in their care, to offer a support network, to improve satisfaction, and to provide them with tools to help reduce their stress and anxiety while undergoing the IVF process. The investigators plan to have four to eight infertility patients and their partners participate in a group at a time, for which they will attend three 1-1.5 hour interactive sessions that are scheduled throughout their first IVF cycle. These sessions will provide additional time for discussion about treatment with providers, learning opportunities on topics of interest to fertility patients, and stress reduction techniques. They will do several surveys before and after the intervention for comparison, including assessment of quality of life, depression, anxiety, resilience, and a knowledge assessment. The investigators will also track the patients to see if they pursue additional treatment in the instance of a negative pregnancy test compared to patients undergoing the standard treatment. The investigators plan to recruit a control group that receives the standard of care treatment here at the University of Iowa.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
Patients and their partners (if present and consenting) will be randomized in a 2:1 fashion to two different treatment arms: A) standard of care in vitro fertilization (IVF) at the investigational institution as well as participating in an additional psychoeducational group or B) standard of care IVF at the investigational institution. The intervention group will consist of three additional evening visits for 1-1.5 hours per session. The sessions will include an interactive educational component addressing usual questions and concerns of IVF patients, such as reviewing common IVF myths, and also more information regarding treatment and technologies. Each session will also include teaching of coping strategies (such as awaiting the pregnancy test, how to cope with insensitive remarks from friends and family) as well as relaxation exercises, such as progressive muscle relaxation and deep breathing.
The patients will be consented at their new IVF visit and will take their initial assessments (FertiQoL, GAD-7, PHQ-9, the Connor-Davidson Resilience Scale, and a knowledge assessment) within 24 hours of the new visit. The patients will be assigned into groups based on when they are going through their IVF stimulations, so they will have similar experiences at similar times. Patients will take their final assessments on the third day after egg retrieval, regardless of group assignment.
When partners are present and consent to the study, they will be treated as a dyad with the patient undergoing oocyte retrieval. Some patients go through treatment alone (i.e. single adults desiring pregnancy) and therefore may not have a partner available to participate. Partners level of involvement in a cycle may very, as may their desire to participate in a psychosocial intervention. As patients and their partners make joint decisions throughout their IVF cycle and the cycle itself has a single outcome, we enrolled partners as dyads with patients when partners were present, but did not require a partner to enroll a patient.
Tipo de estudo
Tipo de estudo
Inscrição (Real)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Iowa
-
Iowa City, Iowa, Estados Unidos, 52242
- University of Iowa Hospitals and Clinics
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- All patients starting their first in vitro fertilization cycle at the University of Iowa Hospitals and Clinics
Exclusion Criteria:
- Patients who have already undergone in vitro fertilization treatment at any institution
- Non-English speakers
- Fertility preservation patients
- Patients using donor oocytes, embryos, or sperm
- Patients taking psychotropic medications for depression or anxiety that have had a dosing adjustment within 3 months of study enrollment
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Experimental: Intervention
Standard of care in vitro fertilization patients randomized to the psychoeducational group intervention. |
The intervention will be three 1-1.5 hour interactive sessions that are scheduled throughout the participant's first in vitro fertilization cycle. These sessions will provide additional time for discussion about treatment with providers, learning opportunities on topics of interest to fertility patients, and stress reduction techniques. |
|
Outro: Control
Standard of care in vitro fertilization patients at our institution. |
Patients will receive the standard of care IVF treatment at the University of Iowa. |
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in female fertility patient quality of life score during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval
|
FertiQoL International (Fertility Quality of Life Questionnaire 2008), scored scale from 0-100, with higher values indicating a higher quality of life and low scores indicating a lower quality of life. |
From enrollment to 2-4 days after oocyte retrieval
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in female GAD-7 score during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval
|
Generalized Anxiety Disorder 7-item scale, with higher scores indicating higher likelihood of an anxiety disorder and lower scores indicating less likelihood of an anxiety disorder. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in female PHQ-9 score during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval
|
Patient Health Questionnaire, with higher score indicating increased likelihood of a depressive disorder and lower scores indicating less likelihood of a depressive disorder. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in female Connor-Davidson Resilience Scale during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval
|
Connor-Davidson Resilience Scale, with higher scores indicating greater resilience, and lower scores indicating lower resilience |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in female knowledge assessment during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval
|
Assessment of knowledge regarding IVF treatment, with higher scores indicating a greater knowledge of IVF treatment, and lower scores indicating less knowledge regarding IVF treatment |
From enrollment to 2-4 days after oocyte retrieval
|
|
Likelihood of continued IVF treatment in the instance of a negative pregnancy test
Prazo: Three months after embryo transfer
|
Patients who are not pregnant after embryo transfer will be followed for three months to assess likelihood to return for additional treatment after negative embryo transfer outcome. |
Three months after embryo transfer
|
|
Change in male fertility patient quality of life score during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval
|
FertiQoL International (Fertility Quality of Life Questionnaire 2008), scored scale from 0-100, with higher values indicating a higher quality of life and low scores indicating a lower quality of life. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in male GAD-7 score during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval
|
Generalized Anxiety Disorder 7-item scale, with higher scores indicating higher likelihood of an anxiety disorder and lower scores indicating less likelihood of an anxiety disorder. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in male PHQ-9 score during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval
|
Patient Health Questionnaire, with higher score indicating increased likelihood of a depressive disorder and lower scores indicating less likelihood of a depressive disorder. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in male Connor-Davidson Resilience Scale during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval
|
Connor-Davidson Resilience Scale, with higher scores indicating greater resilience, and lower scores indicating lower resilience |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in male knowledge assessment during IVF treatment cycle
Prazo: From enrollment to 2-4 days after oocyte retrieval
|
Assessment of knowledge regarding IVF treatment, with higher scores indicating a greater knowledge of IVF treatment, and lower scores indicating less knowledge regarding IVF treatment |
From enrollment to 2-4 days after oocyte retrieval
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Rachel M Whynott, MD, University of Iowa
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Início do estudo
Conclusão Primária (Real)
Conclusão Primária
Conclusão do estudo (Real)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Comportamento
- Adesão e Cumprimento do Tratamento
- Comportamento de saúde
- Aceitação dos Cuidados de Saúde pelo Paciente
- Participação do paciente
- Satisfação do paciente
- Administração de Serviços de Saúde
- Qualidade, acesso e avaliação da assistência médica
- Qualidade de assistência médica
- Indicadores de qualidade, assistência médica
- Padrão de atendimento
Outros números de identificação do estudo
Outros números de identificação do estudo
- 201906788
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .